Novel aspects of posttraumatic stress disorder

August 30, 2012
Novel aspects of posttraumatic stress disorder
© Thinkstock

A multivariate analysis of posttraumatic stress disorder (PTSD) performed by European researchers is expected to improve risk assessment and disease diagnosis.

PTSD refers to the anxiety disorder caused by various psychologically . It is the most common war-related psychiatric disorder occurring among combat veterans and other people exposed to war-related stress.

The objective of the EU-funded 'Psychobiology of posttraumatic stress disorder' (PBPTSD) project was to understand the characteristics, subtypes and risk factors of PTSD, aiming to improve its diagnosis and prevention.

Project partners assessed relevant psychological, biochemical, endocrinological, genetic, physiological and anthropometric parameters in various groups of male subjects. These included patients with war-zone–related PTSD, patients in remission, war-zone–exposed subjects without PTSD and healthy controls. Female subjects also participated in the psychological part of the study.

Biological measurements were made on the Hypothalamo-pituitary-adrenocortical (HPA) axis, and included cortisol receptor and its gene polymorphism, anthropometry, , lipid status, , and sleep and dream disturbances (nightmares).

Results showed that neurocognitive functioning, self control and superior executive functioning were lower in PTSD groups. These traits seemed to define the individual resilience capacity in situations of . Furthermore, higher level of intelligence and memory functioning were the basic neurocognitive factors protecting against developing PTSD after the traumatic event. Collectively, for risk factor assessment, the PBPTSD findings suggested that personality traits and neurocognitive functioning should be measured.

Overall, the PBPTSD study unveiled novel psychological and biological variables that contribute to PTSD and could be used for efficient disease detection. Implementation of these variables for risk assessment is expected to predict the likelihood and outcome of PTSD.

Explore further: PTSD linked to increase risk in heart disease

Related Stories

PTSD linked to increase risk in heart disease

June 1, 2011
(Medical Xpress) -- New research by Dr. Ramin Ebrahimi and his team from the Greater Los Angeles Veterans Administration Medical Center was published in The American Journal of Cardiology and shows a link between post-traumatic ...

Scientists identify new gene linked to PTSD

August 7, 2012
Investigators at Boston University School of Medicine (BUSM) and Veterans Affairs (VA) Boston Healthcare System have identified a new gene linked to post-traumatic stress disorder (PTSD). The findings, published online in ...

Recommended for you

Taking probiotics may reduce postnatal depression

October 18, 2017
Researchers from the University of Auckland and Otago have found evidence that a probiotic given in pregnancy can help prevent or treat symptoms of postnatal depression and anxiety.

Before assigning responsibility, our minds simulate alternative outcomes, study shows

October 17, 2017
How do people assign a cause to events they witness? Some philosophers have suggested that people determine responsibility for a particular outcome by imagining what would have happened if a suspected cause had not intervened.

For older adults, volunteering could improve brain function

October 17, 2017
Older adults worried about losing their cognitive functions could consider volunteering as a potential boost, according to a University of Missouri researcher. While volunteering and its associations with physical health ...

Magic mushrooms may 'reset' the brains of depressed patients

October 13, 2017
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Living near a forest keeps your amygdala healthier

October 13, 2017
A study conducted at the Max Planck Institute for Human Development has investigated the relationship between the availability of nature near city dwellers' homes and their brain health. Its findings are relevant for urban ...

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.